(Q33394245)

English

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Plasmodium falciparum

0 references

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

Egeruan B Imoukhuede

object named as

Egeruan Imoukhuede

7

0 references

Robert Sauerwein

23

object named as

Robert Sauerwein

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

object named as

Will Roeffen

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

object named as

Bart Faber

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

W Ripley Ballou

17

object named as

W Ripley Ballou

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Opokua Ofori-Anyinam

9

object named as

Opokua Ofori-Anyinam

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marie-Claude Dubois

19

object named as

Marie Claude Dubois

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Meta Roestenberg

1

object named as

Meta Roestenberg

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

object named as

Clemens H M Kocken

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

14

object named as

Karina Teelen

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

André van der Ven

21

object named as

Andre van der Ven

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Quirijn de Mast

16

object named as

Quirijn de Mast

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

22

object named as

Alan Thomas

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Ed Remarque

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Erik de Jonge

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rob Hermsen

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hildur Blythman

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Odile Leroy

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Soren Jepsen

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Miranda Arnold

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Vanessa Walraven

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joe Cohen

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stéphane Ascarateil

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

18 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

e3960

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

copyright license

Creative Commons Attribution 4.0 International

18 December 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Apical membrane antigen 1: a malaria vaccine candidate in review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Vaccine immunopotentiators of the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

A review of human vaccine research and development: malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Specificity of the protective antibody response to apical membrane antigen 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

21 June 2018

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity and safety in rhesus macaques

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0003960

21 January 2018

Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602972

31 October 2018

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised declaration of Helsinki. WMA will continue to revise policy as medicine and research changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0003960

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2008PLoSO...3.3960R

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33394245&oldid=1963104882"